Ticker Details
Korro Bio, Inc.
IPO Date:	October 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$108.11M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.92 | 4.38%
Avg Daily Range (30 D):	$0.32 | 2.68%
Avg Daily Range (90 D):	$0.50 | 3.51%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.19M
Avg Daily Volume (90 D):	.38M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	86

Institutional Trades
Total Institutional Trades:	312
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$1.77M
Avg Institutional Trade (90 D):	$1.39M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.47M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.84M
Avg Closing Volume:	124.62K

News

Jan 8, 2026 @ 1:00 PM Korro to Present at the 44th Annual J.P. Morgan He... Source: Na

Mar 14, 2025 @ 12:00 PM KRRO-110 Receives Orphan Drug Designation from U.S... Source: N/A

Nov 8, 2024 @ 7:34 AM 4 Biotech Stocks With AI, Machine Learning Prowess... Source: Professor Ari Zoldan

Sep 19, 2024 @ 10:50 AM Novo Nordisk Just Took a $530 Million Step Onto Mo... Source: The Motley Fool

May 20, 2024 @ 6:30 PM Korro Presents Additional Preclinical Data for KRR... Source: Korro Bio, Inc.

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-1.92	$-2.74	$-2.49
Diluted EPS	$-1.92	$-2.74	$-2.49
Revenue	$1.09M	$1.46M	$2.55M
Gross Profit
Net Income / Loss	$-18.06M	$-25.77M	$-23.39M
Operating Income / Loss	$-19.24M	$-27.2M	$-25.02M
Cost of Revenue
Net Cash Flow	$-9.46M	$-30.53M	$8.5M
PE Ratio